Close
AI in Healthcare & Pharma Summit Boston 2026

7 Potential Drivers of The Life Sciences Landscape In 2024

The year 2023 was indeed quite a challenging year for the life sciences industry, which was marked by a chilly biotech financing environment, uncertainty...

Synthetic Antibiotics Way To Go For Critical Chronic Issues

Antimicrobial Resistance- AMR as it is referred to, is rising, and an AMR review that was commissioned by the UK Government has gone on...

The Rising Challenges In The Path of Global Pharma In 2024

Certain tectonic shifts in the healthcare market have gone on to push the pharma sector toward painful transformations in recent years. It is indeed...

Federal, State Drug Pricing Plans In US Brewing Deep Issues

The pharmaceutical sector has gone on to face pressure as well as uncertainty in 2023, and that is in all likelihood going to continue...

Biopharma Sector Witnesses M&A Revival Come Back On Track

It is worth noting that the biopharmaceutical sector has gone on to experience a revival when it comes to mergers and acquisitions in the...

Synergising SaaS & Cloud Comm With AI For Better Pharma

The pharmaceutical backdrop is going through a remarkable shift pushed by disruptive technologies: Software as a Service- SaaS, Infrastructure as a Service- IaaS as...

Pharma In 2024: The Support & Challenge On Financial Aspect

As per the results of a study done by GlobalData, the top issues when it comes to the pharmaceutical industry in 2024 are going...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...